These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2029400)

  • 1. Alkaline phosphatase. A marker in prostatic cancer?
    Høisaeter PA
    Acta Oncol; 1991; 30(2):171-2. PubMed ID: 2029400
    [No Abstract]   [Full Text] [Related]  

  • 2. Is acid phosphatase (PAP) still justified in the management of prostatic cancer?
    Kontturi M
    Acta Oncol; 1991; 30(2):169-70. PubMed ID: 1709356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor markers in prostate cancer.
    Cooper EH; Robinson MR; Whelan P; Ferro MA
    Cancer; 1992 Jul; 70(1 Suppl):225-9. PubMed ID: 1376192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal alkaline phosphatase: a marker for individual follow-up in patients with advanced prostatic cancer.
    Wechsel HW; Petri E; Bichler KH
    Urol Int; 1997; 58(2):80-3. PubMed ID: 9096267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of acid and alkaline phosphatase determinations in the diagnosis of prostatic cancer.
    Goldberg DM; Ellis G
    J Clin Pathol; 1973 May; 26(5):387-8. PubMed ID: 4123533
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of biochemical markers in the management of disseminated prostatic cancer.
    Mulders PF; Fernandez del Moral P; Theeuwes AG; Oosterhof GO; van Berkel HT; Debruyne FM
    Eur Urol; 1992; 21(1):2-5. PubMed ID: 1376692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clue to metastasis in prostate cancer.
    Scott WW
    Geriatrics; 1971 Oct; 26(10):46. PubMed ID: 5099241
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
    Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
    J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placenta-like isoenzyme of alkaline phosphatase in prostatic cancer.
    Schmidt JD; Slack NH; Chu TM; Murphy GP
    J Urol; 1982 Mar; 127(3):457-9. PubMed ID: 7062417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of skeletal alkaline phosphatase and prostate-specific antigen in the diagnosis of bone metastasis in cancer of the prostate.
    Wolff JM; Ittel T; Borchers H; Brauers A; Jakse G
    Urol Int; 1998 Oct; 61(1):12-6. PubMed ID: 9792976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.
    Lorente JA; Valenzuela H; Morote J; Gelabert A
    Eur J Nucl Med; 1999 Jun; 26(6):625-32. PubMed ID: 10369948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
    Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
    J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase.
    Curatolo C; Ludovico GM; Correale M; Pagliarulo A; Abbate I; Cirrillo Marucco E; Barletta A
    Eur Urol; 1992; 21 Suppl 1():105-7. PubMed ID: 1385127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audit and its impact in the management of advanced prostatic cancer.
    Rana A; Chisholm GD; Christodoulou S; McIntyre M; Elton RA
    Br J Urol; 1993 Oct; 72(4):478-83. PubMed ID: 8261306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
    Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
    Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone scintigraphy, plasma ALP, TAP and PAP in patients with prostatic cancer].
    Imamura A; Hoshi H; Jinnouchi S; Samejima M; Watanabe K
    Kaku Igaku; 1988 Feb; 25(2):177-81. PubMed ID: 3386031
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma.
    Desoize B; Amico S; Larbre H; Coninx P; Jardillier JC
    Clin Biochem; 1991 Oct; 24(5):443-6. PubMed ID: 1760884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase.
    Akimoto S; Inomiya H; Akakura K; Shimazaki J; Ito H
    Jpn J Clin Oncol; 1997 Aug; 27(4):258-62. PubMed ID: 9379515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DETERMINATION OF PROSTATIC PHOSPHATASE IN BLOOD SERUM].
    PINHEIRO J
    Hospital (Rio J); 1965 Feb; 67():283-92. PubMed ID: 14329942
    [No Abstract]   [Full Text] [Related]  

  • 20. [DETERMINATION OF ACID AND ALKALINE SERUM PHOSPHATASES AS A ROUTINE METHOD. II. STATISTICAL EVALUATION OF RESULTS AND THEIR CLINICAL SIGNIFICANCE].
    BROCK N; HOHORST HJ; SCHNEIDER B; WILMANNS H
    Arzneimittelforschung; 1964 Jul; 14():762-8. PubMed ID: 14344715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.